Lymphoma and tuberculosis: Temporal evolution of dual pathology on sequential 18F-FDG PET/CT

Clinical Nuclear Medicine

Volumn 39, Issue 8, 2014, Pages 736-737

  Mukherjee, Anirban ^a   Sharma, Punit ^a   Karunanithi, Sellam ^a   Dhull, Varun Singh ^a   Kumar, Rakesh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

18F FDG; Hodgkin lymphoma; PET CT; Tuberculosis

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; TUBERCULOSTATIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADJUVANT RADIOTHERAPY; ADULT; ANTIBIOTIC THERAPY; AXILLARY LYMPH NODE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CERVICAL LYMPH NODE; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HODGKIN DISEASE; HUMAN; HUMAN CELL; REED STERNBERG CELL; SHORT SURVEY; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE; YOUNG ADULT; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TUBERCULOSIS;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS;

EID: 84941061262     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000368     Document Type: Short Survey

References (8)

1. Sioka C. The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood. Eur J Pediatr. 2013;172:733-738.
2. Donaldson SS, Link MP, Weinstein HJ, et al. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007;25:332-337.
3. Kung FH, Schwartz CL, Ferree CR, et al. POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2006;28:362-368.
4. Khan SA, Wingard JR. Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr. 2001;29:31-36.
5. Kamboj M, Kent AS. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42:1592-1595.
6. Ouedraogo M, Ouedraogo SM, Cisse R, et al. Active tuberculosis in a patient with Hodgkin's disease. A case report. Rev Pneumol Clin. 2000;56:33-35.
7. Audebert F, Schneidewind A, Hartmann P, et al. Lymph node tuberculosis as primary manifestation of Hodgkin's disease. Med Klin (Munich). 2006;101: 500-504.
8. Martinez V, Castilla-Lievre MA, Guillet-Caruba C, et al. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis. 2012;16:1180-1185.